Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/3-Figure1-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
Interim PET in Diffuse Large B-Cell Lymphoma | Journal of Nuclear Medicine
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management - Marchi - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Frontiers | Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma - ScienceDirect
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/6-Figure3-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar
Diffuse Large B-Cell Lymphoma | NEJM
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma | NEJM
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/5-Figure2-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
PDF) Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis
Non-Hodgkin lymphoma - Clinical
![A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/9658/1/fig-1-2x.jpg "A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma [PeerJ]")